about
Phlebotomy for hereditary haemochromatosisRedox mechanisms in hepatic chronic wound healing and fibrogenesisVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinDysregulation of iron and copper homeostasis in nonalcoholic fatty liverOvine uterine space restriction alters placental transferrin receptor and fetal iron status during late pregnancyEvidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective studyInvestigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter.Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection.Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.Hepcidin is an antibacterial, stress-inducible peptide of the biliary system.Gender-related variations in iron metabolism and liver diseases.Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis.Molecular diagnosis of hemochromatosis.Prohepcidin levels in refractory anaemia caused by lead poisoningDiagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.Body iron, serum ferritin, and nonalcoholic fatty liver disease.Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans.Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations.The RGM/DRAGON family of BMP co-receptorsHepcidin modulation in human diseases: from research to clinic.Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosis.Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney diseaseBody iron metabolism and pathophysiology of iron overload.Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.Reduced serum hepcidin levels in patients with chronic hepatitis C."Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levelsIron homeostasis in the metabolic syndrome.HFE mutations and iron in hemodialysis patients.Porphyria cutanea tarda: an intriguing genetic disease and marker.Hypogonadotropic hypogonadism in men with hereditary hemochromatosis.Dietary-induced gestational iron deficiency inhibits postnatal tissue iron delivery and postpones the cessation of active nephrogenesis in rats.Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients.Preparation and Practical Applications of 2',7'-Dichlorodihydrofluorescein in Redox Assays.
P2860
Q24236779-22C1A082-C8D0-411C-94CA-94EAA6770418Q24656684-B928B15A-7FF5-4A93-B229-B983EAD15722Q26750865-F4E46FAD-9E71-4A5B-9DE8-870657D8D73BQ26996539-6775799A-44EA-4629-99E6-30A68D2BCEDDQ28384197-019B7ABE-4D62-4965-A6DE-1C5F85B4226CQ28536213-0D3AF5D1-BD77-4450-9D23-A29DA1613A8AQ30487384-A92259DA-A600-424E-AEA5-3F104311BDE0Q30747665-B650FD64-6C10-48A8-87CF-8A701DCDD1D8Q33471093-FCBB28D2-2616-47EC-B315-8CE61801EBD3Q33615967-E115DABC-6065-4DEE-8F83-B3C4867D48CDQ33724041-31739BC9-32AF-4DCD-9D84-F1FB183190CCQ33753221-2B263D77-B0EF-4010-9060-F2A7B4746EC4Q33766381-25D4B5CF-D969-494C-9B6F-89BB7DAD93AFQ33808985-77707FC7-3C6F-401C-86EA-09146B6FAD34Q34391646-13A1B709-F17F-455B-ABDE-E7908A3C9D80Q34556776-2E87637E-ED47-4245-893B-6D7C0BD20897Q34636616-6811195B-76CF-4E09-924B-DDDF119B8BF2Q34785164-96D1F74B-D6B2-45B2-B802-5027C67E5000Q35144263-1045CD07-A776-4311-82BE-79F752224165Q35890608-44C483CD-CD37-4862-8FA5-DC28494F9FDCQ35920651-D93BE2D4-4E9F-48A3-8AF1-8458317806CFQ36031314-605D3CFE-DAF5-476B-BA5B-37882351DFB8Q36142416-FB804BF8-D395-4492-98CE-3DC506BCEDACQ36373567-44B13CF6-AC00-4A2B-A5EA-D636745CE2B0Q37021503-E62AFE02-368C-4009-A4D4-415B619D2E48Q37026226-91371696-4E56-4307-BFFB-F52A0C8D77DBQ37122273-1208F284-0336-4E7C-AD0F-54C4773DB784Q37141378-CEE1D1CC-B318-40AA-8706-E077AE693F35Q37195412-C452E9A0-4C72-4257-BD40-CF0BCFA0EB06Q37205002-EEA24CF3-C2B1-4F7F-8DE8-F279F47AAEB7Q37362755-6E3695B9-77F6-485E-ADA5-19DE531720CEQ37387659-8176A202-2CAC-473C-8B05-8A858289D2E7Q37716856-99D9016F-7B99-45BB-84A4-5F045F0AFAF3Q38071663-A3F10A44-8793-422D-8990-5B8F88E387CFQ38907419-851DD48E-FE31-4DED-866F-6E20278B5373Q39189271-53339519-A104-4DF1-B9CB-8828F8D54ABEQ39427239-BDCC3641-5EDD-483F-866C-B0E58AB6E903Q41566861-287886A5-7183-4929-9E77-88D35C7F4BB0Q41614697-7DC65D2D-F0B2-4399-8EC0-7682E5B09540Q41917876-80608FEA-1169-4468-89E9-FFBCB6C7F11A
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hemochromatosis: an endocrine liver disease.
@en
type
label
Hemochromatosis: an endocrine liver disease.
@en
prefLabel
Hemochromatosis: an endocrine liver disease.
@en
P356
P1433
P1476
Hemochromatosis: an endocrine liver disease
@en
P2093
Antonello Pietrangelo
P304
P356
10.1002/HEP.21886
P407
P577
2007-10-01T00:00:00Z